Literature DB >> 22105603

How close is evidence to truth in evidence-based treatment of mental disorders?

Hans-Jürgen Möller1.   

Abstract

Given the importance of the term 'evidence' in evidence-based medicine (EBM), the meaning of this term is evaluated, going back to the philosophical tradition and current meaning of the terms 'evidence' and 'truth'. Based on this, current problems in the definition of evidence and in the grading of evidence in EBM are described, taking examples from the field of psychiatry and especially pharmacopsychiatry. These problems underline that the use of the term evidence in EBM is inconsistent and inconclusive. This should be fairly stated in all EBM-related publications, especially in EBM-based guidelines, to avoid severe misunderstandings in and outside the field of psychiatry. Although EBM might have increased empirically driven rational decision-making in psychiatry/medicine, the current limitations should be carefully considered.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22105603     DOI: 10.1007/s00406-011-0273-8

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  71 in total

Review 1.  Flawed meta-analyses comparing psychotherapy with pharmacotherapy.

Authors:  D F Klein
Journal:  Am J Psychiatry       Date:  2000-08       Impact factor: 18.112

Review 2.  Day centres for severe mental illness.

Authors:  J Catty; T Burns; A Comas
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 3.  World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.

Authors:  Peter Falkai; Thomas Wobrock; Jeffrey Lieberman; Birte Glenthoj; Wagner F Gattaz; Hans-Jürgen Möller
Journal:  World J Biol Psychiatry       Date:  2005       Impact factor: 4.132

Review 4.  Is evidence sufficient for evidence-based medicine?

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11       Impact factor: 5.270

5.  Principle standards and problems regarding proof of efficacy in clinical psychopharmacology.

Authors:  Hans-Jürgen Möller; Karl Broich
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-02       Impact factor: 5.270

6.  Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials.

Authors:  Florian Seemüller; Hans-Jürgen Möller; Michael Obermeier; Mazda Adli; Michael Bauer; Klaus Kronmüller; Florian Holsboer; Peter Brieger; Gerd Laux; Wolfram Bender; Isabella Heuser; Joachim Zeiler; Wolfgang Gaebel; Rebecca Schennach-Wolff; Verena Henkel; Michael Riedel
Journal:  J Clin Psychiatry       Date:  2010-08-10       Impact factor: 4.384

7.  [Evidence-based medicine and 'The Cochrane Collaboration'].

Authors:  T Kawamura; A Tamakoshi; K Wakai; Y Ohno
Journal:  Nihon Koshu Eisei Zasshi       Date:  1999-06

8.  Antidepressant-associated maniform states in acute treatment of patients with bipolar-I depression.

Authors:  R Bottlender; D Rudolf; A Strauss; H J Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1998       Impact factor: 5.270

Review 9.  How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials.

Authors:  S Leucht; D Arbter; R R Engel; W Kissling; J M Davis
Journal:  Mol Psychiatry       Date:  2008-01-08       Impact factor: 15.992

Review 10.  [Evidence-based medicine. How to use biomedical literature to solve clinical problems. Italian Group on Evidence-Based Medicine-GIMBE].

Authors:  A Cartabellotta; G Montalto; A Notarbartolo
Journal:  Minerva Med       Date:  1998-04       Impact factor: 4.806

View more
  5 in total

1.  Effectiveness of antipsychotic maintenance therapy with quetiapine in comparison with risperidone and olanzapine in routine schizophrenia treatment: results of a prospective observational trial.

Authors:  Reinhold Kilian; Tilman Steinert; Wiltrud Schepp; Prisca Weiser; Susanne Jaeger; Carmen Pfiffner; Karel Frasch; Gerhard W Eschweiler; Thomas Messer; Daniela Croissant; Thomas Becker; Gerhard Längle
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-04-22       Impact factor: 5.270

2.  Influence of sociodemographic and socioeconomic features on treatment outcome in RCTs versus daily psychiatric practice.

Authors:  R van der Lem; P M Stamsnieder; N J A van der Wee; T van Veen; F G Zitman
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-12-05       Impact factor: 4.328

Review 3.  The psychiatric interview: validity, structure, and subjectivity.

Authors:  Julie Nordgaard; Louis A Sass; Josef Parnas
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-09-23       Impact factor: 5.270

4.  From pathophysiological aspects towards unravelling the neurobiological background of cognitive deficits.

Authors:  Peter Falkai; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-06       Impact factor: 5.270

5.  A non-linear dynamical approach to belief revision in cognitive behavioral therapy.

Authors:  David Kronemyer; Alexander Bystritsky
Journal:  Front Comput Neurosci       Date:  2014-05-15       Impact factor: 2.380

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.